Peptidoglycan recognition proteins (PGRPs) are mediators of innate immunity and recently have been implicated in developmental regulation. To explore the interplay between these two roles, we characterized a PGRP in the host squid Euprymna scolopes (EsPGRP1) during colonization by the mutualistic bacterium Vibrio fischeri. Previous research on the squid-vibrio symbiosis had shown that, upon colonization of deep epithelium-lined crypts of the host light organ, symbiont-derived peptidoglycan monomers induce apoptosismediated regression of remote epithelial fields involved in the inoculation process. In this study, immunofluorescence microscopy revealed that EsPGRP1 localizes to the nuclei of epithelial cells, and symbiont colonization induces the loss of EsPGRP1 from apoptotic nuclei. The loss of nuclear EsPGRP1 occurred prior to DNA cleavage and breakdown of the nuclear membrane, but followed chromatin condensation, suggesting that it occurs during late-stage apoptosis. Experiments with purified peptidoglycan monomers and with V. fischeri mutants defective in peptidoglycan-monomer release provided evidence that these molecules trigger nuclear loss of EsPGRP1 and apoptosis. The demonstration of a nuclear PGRP is unprecedented, and the dynamics of EsPGRP1 during apoptosis provide a striking example of a connection between microbial recognition and developmental responses in the establishment of symbiosis.
Introduction
Peptidoglycan recognition proteins, or PGRPs, are a protein family of innate immune system effectors and receptors conserved across the animal kingdom (Werner et al., 2000; Goodson et al., 2005; Dziarski and Gupta, 2006b; Coteur et al., 2007; Zhang et al., 2007) . PGRPs mediate host responses to the bacterial cell envelope component, peptidoglycan (PGN). In-depth research on the PGRPs in the last 10 years has principally focused on biochemical characterizations of the activity and binding specificity of the purified proteins, as well as the genetics of their in vivo function in Drosophila melanogaster (Kaneko et al., 2004; Filipe et al., 2005; Dziarski and Gupta, 2006a; Lim et al., 2006; Lu et al., 2006; Park et al., 2007) . For example, in vitro studies have demonstrated that the characteristic PGRP domain binds specifically to PGN ligands (Chang et al., 2006; Swaminathan et al., 2006) and in some isoforms also cleaves the substrate (Steiner, 2004) . Genetic analyses have implicated these behaviours in the regulation of downstream response pathways (Michel et al., 2001; Kaneko et al., 2004; Bischoff et al., 2006) .
These studies have defined similarities and differences among the vertebrates and invertebrates. In both animal groups, some PGRPs can act to attenuate the inflammatory response by degrading the PGN through N-acetylmuramyl-L-alanine amidase activity Bischoff et al., 2006; Zaidman-Remy et al., 2006) , which requires a cysteine residue in the PGN-binding pocket. In this enzymatic behaviour, the stem peptide is cleaved from the sugar backbone of PGN, resulting in products that are less immunogenic (Bischoff et al., 2006) . Although all mammalian PGRPs described thus far are reported to be secreted proteins, the invertebrate homologues can act as receptors for PGN, a feature reflected in their localization. The invertebrate PGRPs are predicted to be either intracellular, membrane-associated or secreted (Royet and Dziarski, 2007) , although few studies have defined precise cellular localization (Dziarski et al., 2003; Kaneko et al., 2006; Gupta, 2008) . The more varied predicted localization of invertebrate PGRPs correlates with broader function. In Drosophila, PGRPs have been implicated in the regulation of apoptosis and development (Bischoff et al., 2006; Maillet et al., 2008) , activation or dampening of the immune response (Yoshida et al., 1996; Takehana et al., 2002; Kaneko et al., 2004; Maillet et al., 2008) , control of phagocytosis (Ramet et al., 2002) and as direct immune effectors (Mellroth and Steiner, 2006) .
The PGRPs have been implicated not only in mediating responses to microbial pathogens, but also in the dynamics of mutualistic symbioses in invertebrates (Anselme et al., 2006; 2008; Bischoff et al., 2006) . The binary association between the Hawaiian bobtail squid Euprymna scolopes and the marine bacterium Vibrio fischeri has been used for the last 20 years as a model for the study of mutualistic symbioses (for reviews see Nyholm and McFall-Ngai, 2004; Visick and Ruby, 2006) . The analysis of an EST database constructed from the symbiotic tissues of juvenile E. scolopes revealed the expression of four host PGRPs, EsPGRP1-4, in these bacteriacontaining tissues (Goodson et al., 2005) . This finding suggested the squid-vibrio system could be a model for the study of these proteins in mutualistic associations. In this naturally occurring, binary symbiosis, the partners can be experimentally manipulated. This feature facilitates the discovery of the molecular underpinnings of the cellular interactions between host and symbiont. In addition, molecular genetics have been developed in V. fischeri, providing the opportunity to study changes in the host in response to genetic alterations in key symbiont characters (Visick and Ruby, 2006) .
A key feature of this symbiosis is its exclusivity: only V. fischeri is capable of colonizing host tissues and inducing morphogenesis (McFall-Ngai and Ruby, 1991) . The exclusivity is achieved through the multiple steps required for colonization, including competitive dominance during aggregation in host mucus, locomotion to the light-organ pores and resistance to the oxidatively stressful environment of the ducts (Nyholm et al., 2004) . V. fischeri cells appear to signal morphogenesis from the light-organ interior, which is several cell layers away from the tissue layer that regresses ( Fig. 1) (Montgomery and McFall-Ngai, 1994; Doino and McFall-Ngai, 1995) . Thus, either the morphogenetic signals are sensed by the internal epithelia and responses are transduced through the tissues to the superficial epithelium, or the bacterial signal molecules are transported through host tissues to the sites of morphogenesis where they would act directly on host cells. In either case, the development is irreversibly triggered at 12 h and completed by 96 h (Doino et al., 1995) .
Studies of these early developmental events implicated the cell envelope constituents of V. fischeri, specifically derivatives of lipopolysaccharide (LPS) and PGN, in the triggering of host tissue morphogenesis. V. fischeri is one of the few bacterial species known to release the tetrapeptide PGN monomer, 'tracheal cytotoxin' (TCT) (Rosenthal et al., 1987; Cloud-Hansen et al., 2006) , which mediates the destruction of epithelial tissues in certain pathogenic associations (Cookson et al., 1989; Cloud and Dillard, 2002) . Further, as stated above, only V. fischeri can enter the crypts of E. scolopes to present these morphogens. Light-organ development can be triggered in the absence of V. fischeri by exposing juvenile squid to the synergistic activity of TCT and the lipid A component of LPS (Koropatnick et al., 2004) . LPS alone fails to drive lightorgan development but will induce chromatin condensation without progression into the later stages of apoptosis, such as DNA fragmentation . When added as pharmacological agents, which are readily taken up into the crypt spaces, TCT synergizes with LPS to mimic symbiont-induced chromatin condensation and epithelial regression (Koropatnick et al., 2004) . While the effects of TCT and LPS on late-stage apoptosis were not investigated, this study led to the model that these biomolecules are sufficient to induce light-organ morphogenesis.
The finding that V. fischeri PGN is critical for morphogenesis, coupled with the discovery of expression of PGRPs in the juvenile light organ, suggested that the EsPGRPs are good candidates to mediate the host response to bacterial PGN products. EsPGRP1 is of particular interest because its expression is upregulated during early morphogenesis (Chun et al., 2008) . The derived amino acid sequence and lack of a putative signal peptide predicted that EsPGRP1 is a 23.5 kDa intracellular protein (Goodson et al., 2005) . The presence of conserved amino acid residues required for N-acetylmuramyl-L-alanine amidase activity suggested that EsPGRP1 has PGN amidase activity.
In this study, we sought to describe the role of EsPGRP1 during early postembryonic development of the light organ. We observed this protein in host tissues of uncolonized animals and during colonization by wild-type V. fischeri or by TCT-production mutants, as well as during the host response to pharmacological exposure to PGN and LPS derivatives. The data presented here provide evidence that PGRPs are components of the host response to mutualistic microbial associations and are integral components of the developmental response to bacterial cues in this symbiosis.
Results

Characterization of the EsPGRP1 protein and an anti-EsPGRP1 antibody
Western blot analyses determined that EsPGRP1 is present in the soluble fraction of lysed cells of whole newly hatched animals. The EsPGRP1 antibody ( Fig. 2A) reacted with a peptide at~24 kDa, consistent with the molecular mass predicted by the derived amino acid sequence (Fig. 2B) . To test the prediction that EsPGRP1 has amidase activity (Goodson et al., 2005) , we transfected a FLAG-tagged EsPGRP1 expression plasmid into Drosophila S2* cells. A protein fraction enriched for EsPGRP1-FLAG was generated from these transfectants using anti-FLAG affinity chromatography (Fig. 2C ). This fraction was coincubated with TCT. Within 1 h, 64 ng of the EsPGRP1-enriched protein fraction degraded over 2.5 mg of TCT (Fig. 2D) , in a manner consistent with PGRP amidase activity . In contrast, 24 mg of crude protein extract of S2* cells was found to have no catalytic activity against TCT. The potential for direct interaction between EsPGRP1 and PGN was further supported by the appearance of zones of clearing on a PGN-gel zymogram at positions corresponding to EsPGRP1 bands on a companion immunoblot (Fig. S1 ).
EsPGRP1 localized to epithelial nuclei
To gain insight into the possible functions of EsPGRP1 in the symbiosis, we performed confocal immunocytochem- Ciliated epithelial fields specific to the surface of the juvenile light organ promote colonization by the symbiont. These ciliated epithelial fields that undergo morphogenesis include the anterior appendage (aa), the posterior appendage (pa) and the ciliated ridge (cr). C. A timeline illustrating relevant characteristics of the early symbiosis. V. fischeri cells aggregate near the ciliated epithelial fields and enter the light organ around 4-6 h post hatching. Within hours of successful colonization of the deep crypts of the light organ, the symbionts deliver an irreversible signal that triggers an extensive developmentally programmed tissue destruction (morphogenesis) of the light organ into a mature form lacking the ciliated epithelial fields. ac, antechamber; d, ducts; dc, deep crypts; EPS, exopolysaccharide; hg, hindgut; p, pores. istry to localize the protein in tissues and cells. Reactivity to the EsPGRP1 antibody occurred in the nuclei of epithelia throughout the body (Fig. 3 and Fig. S2 ), including those of the light organ, gills, gut and mantle. Unlike other epithelia, where variation in staining intensity occurs among cells, nuclear localization of EsPGRP1 in the superficial ciliated epithelium of the light organ was uniform from cell-to-cell in hatchling and in non-symbiotic animals (n > 100 individuals, from the eggs of 10 different females) (Fig. 3A-D) . EsPGRP1 was detected at low levels in the connective tissue matrix of the light organ, and when present, appeared to be entirely non-nuclear ( Fig. 3B and D) . The nuclear distribution of EsPGRP1 was heterogeneous; anti-EsPGRP1 antibodies most intensely stained subnuclear regions that were weakly labelled for nucleic acids (Figs 3-6 ), suggesting that EsPGRP1 does not directly bind to DNA. Pre-immune serum did not react detectably with host tissues at comparable gain settings on the confocal microscope (Fig. S3) , and antibodies generated to the other three EsPGRPs did not show significant reactivity in the nuclei (data not shown).
Absence of nuclear EsPGRP1 was correlated with symbiosis-induced late-stage apoptosis in the light organ
To understand the function of EsPGRP1 during colonization, we first examined its localization at 24 h. All morphogenic processes of the superficial light-organ epithelia are underway at this time. Whereas all epithelial cells of nonsymbiotic animals stained similarly, a subset of the epithelial nuclei in 24-h symbiotic light organs did not stain for EsPGRP1 (Fig. 4A) . The EsPGRP1-negative nuclei contained condensed chromatin, and cells with these phenotypes occurred at a frequency similar to that observed previously for apoptotic cells in the 24-h symbiotic light organ (Foster et al., 1998; Koropatnick et al., 2004) . These data suggested that EsPGRP1-negative nuclei occur in the cells undergoing apoptosis. This hypothesis was supported by the finding that all nuclei undergoing DNA degradation, that is, were TUNEL-positive, a characteristic of the later stages of programmed cell death in this system (Foster et al., 1998) , also lacked EsPGRP1 (Fig. 4B ). The reverse did not occur, i.e. only a subset of EsPGRP1-negative nuclei was TUNEL-positive. These observations provide evidence that nuclear loss of EsPGRP1 occurs prior to late-stage apoptosis.
To determine the relationship of EsPGRP1 loss to the integrity of the nucleus during apoptosis, we examined EsPGRP1 localization in the context of known nuclear apoptosis events. We observed an alternate intranuclear distribution of EsPGRP1, in which the DNA appeared condensed and EsPGRP1 appeared to fill the remainder of the nucleoplasm (Fig. 4C ). The alternate EsPGRP1/ DNA distribution was observed very rarely, suggesting that this distribution is highly transient. In addition, we investigated the temporal/spatial relationship between EsPGRP1 and nucleoporins, which during apoptosis undergo spatial redistribution in the nuclear membrane and are eventually degraded (Kihlmark et al., 2001) . In EsPGRP1/nucleoporin costaining experiments in sym- A. An alignment of the EsPGRP C-termini (arrow indicates additional C-terminal sequence for EsPGRP3). Boxed area highlights antigen sequence used for anti-EsPGRP1 antibody generation. *, identical residues; :, conserved substitutions; ., semi-conserved substitutions. B. A representative immunoblot of E. scolopes tissue. The anti-EsPGRP1 antibody reacts with a major band in the aqueous soluble fraction at~24 kDa. C, cytoplasmic (aqueous) fraction; M, membrane (SDS soluble) fraction. C. Anti-FLAG immunoblot and companion gel of 24 mg crude protein extract from untransfected Drosophila S2* cells and 256 ng of an EsPGRP1-enriched fraction of S2* cells transfected with an EsPGRP1-FLAG expression construct. The arrow indicates an anti-FLAG reactive band at the expected molecular weight for EsPGRP1. D. An EsPGRP1-enriched EsPGRP1/S2* fraction degraded TCT in vitro, but a protein extract of untransfected S2* cells had no effect on TCT levels. Bars indicate mass of TCT (left axis) in each reaction, and white peaks inside bars are the TCT peaks following treatment as the absorbance at 215 nm on a reverse-phase HPLC chromatograph (right axis). UnT/S2*, untransfected S2* cell extract; EsPGRP1/S2*, EsPGRP1-enriched fraction of S2* cells transfected with pJT28; mock rxn, TCT incubated in reaction buffer for 3 h; TCT, 7 ml 1 mM TCT loaded directly onto HPLC column. biotic animals, EsPGRP1 was lost from the nucleus prior to the redistribution and breakdown of the nucleoporins (Fig. 4D ). Taken together, these data suggest that nuclear loss of EsPGRP1 rapidly follows chromatin condensation and precedes the breakdown of the nuclear envelope, linking nuclear loss of EsPGRP1 to the apoptotic pathway.
Timing of EsPGRP1 loss suggested a role in late-stage apoptosis and morphogenesis
As described above, all TUNEL-positive nuclei were EsPGRP1-negative while only a subset of EsPGRP1-negative nuclei was TUNEL-positive ( Fig. 4B ), suggesting that nuclear loss of EsPGRP1 occurs prior to late-stage apoptosis. To characterize the timing of these processes, we enumerated EsPGRP1-negative and TUNEL-positive nuclei in anterior appendages from both symbiotic and non-symbiotic light organs at the following time points: 8, 12, 13, 18 and 24 h post hatching ( Fig. 5A and B). The loss of nuclear EsPGRP1 was first detected in symbiotic animals at 12 h, a time point coincident with the delivery of the irreversible signal for morphogenesis. In addition, we observed significantly greater numbers of EsPGRP1-negative nuclei at 13 h, only 1 h after the morphogenesis signal. An increased level of EsPGRP1-negative nuclei was present in symbiotic animals at each time point up to 24 h. In contrast, TUNEL-positive nuclei were first detected in symbiotic light organs at 13 h, and greater numbers were not observed until 18 h, followed by another significant increase at 24 h. Greater numbers of both EsPGRP1-negative (13-24 h) and TUNEL-positive (18-24 h) nuclei were found in symbiotic compared with non-symbiotic light organs, consistent with these events being components of colonization-induced morphogenic tissue destruction. Beyond 24 h, cells were rapidly lost from the anterior appendage due to morphogenesis and counts from these later time points cannot be compared with the earlier time points. These data provide evidence Fig. 3 . Localization of EsPGRP1 in host tissue. Confocal immunocytochemistry of hatchling and 24 h non-symbiotic E. scolopes localized EsPGRP1 to epithelial nuclei. A. A low-magnification image of the light organ. Anti-EsPGRP1 antibodies intensely labelled the ciliated epithelial fields on the lateral surfaces of the light organ. B-D. Representative higher-magnification images displaying the anterior appendage and a portion of the more medial ciliated field (dashed box in A). The nuclei of these epithelial cells (aa and cr) labelled strongly with the anti-EsPGRP1 antibody (green arrows), whereas non-epithelial nuclei of the underlying tissues (ctm) appeared devoid of EsPGRP1 (white arrowheads). E. Epithelia across the body contain nuclear EsPGRP1. A representative image taken from gill tissue is shown, note variations of staining intensity in the nuclei (white arrows). aa, anterior appendage; cr, ciliated ridge; ctm, connective tissue matrix; hg, hindgut; p, pores; pa, posterior appendage. EsPGRP1, green; DNA, red; actin cytoskeleton, blue. Fig. 4 . Loss of EsPGRP1 during progression through apoptosis. Confocal microscopy of symbiotic light organs revealed nuclear loss of EsPGRP1 and entry into late-stage apoptosis in anterior appendage epithelial nuclei. A. Micrographs of an optical section of the anterior appendage: individual channels on the left, merged image on the right. Colonization of the light organ by V. fischeri for 24 h induces a subset of nuclei in the ciliated epithelial fields to lose EsPGRP1 staining (e.g. white arrowheads). B. High-magnification micrographs of epithelial cells from the anterior appendage. TUNEL staining of cleaved DNA only occurs in nuclei that have lost EsPGRP1 staining (yellow arrows), but not all EsPGRP1-negative nuclei are TUNEL-positive (white arrowhead). Dashed box in inset indicates area of the anterior appendage shown in high magnification. C. Micrograph of an anterior appendage. Dashed box indicates area of high magnification in right panel that displays a transient alteration of intranuclear (based on size and shape) localization of EsPGRP1 staining after chromatin condensation but prior to the loss of EsPGRP1 signal from the nucleus (yellow arrowhead) as seen in (A). Note also that haemocytes (h), which have migrated to the light organ blood sinus, fail to stain with EsPGRP1. Colour palette is the same as in (B): EsPGRP1, green; DNA, red; TUNEL, blue. D. High-magnification micrographs of anterior appendage epithelial cells from non-symbiotic and symbiotic animals. Labelling of the nucleoporins (red) with the monoclonal Ab 414 indicates that loss of EsPGRP1 from the nucleus (blue) occurs prior to the dissolution of the nuclear membrane (red arrowheads). Inset in sym panel exhibits an EsPGRP1-negative nucleus with complete breakdown of the nuclear envelope.
that nuclear loss of EsPGRP1 precedes entry into latestage apoptosis. As it is not possible to follow an individual cell through the entire process, it cannot be ruled out that a subset of EsPGRP1-negative nuclei never become TUNEL-positive.
Because the onset of nuclear-EsPGRP1 loss coincided with the delivery of an irreversible morphogenic signal by V. fischeri at 12 h (Doino et al., 1995) , we hypothesized that the EsPGRP1 phenotype was a component of the host response to this morphogenesis signal. To test this hypothesis, we performed 'curing' experiments to determine whether EsPGRP1 loss is also a component of the irreversible morphogenic programme. In these experiments, symbiotic juvenile E. scolopes were treated with the antibiotic chloramphenicol to clear the crypts of symbionts either before or after the 12 h time point and were subsequently assayed at 24 h (Fig. 5C ). Previous experiments showed that only a small proportion of animals chloramphenicol and scored for EsPGRP1-negative and TUNEL-positive nuclei in the anterior appendage at 24 h. The 95% confidence intervals for EsPGRP1-negative and TUNEL-positive nuclei were determined for 24 h symbiotic animals and the values for each animal from the two cured and the non-symbiotic groups were compared with the 24 h sym CI. If the number of EsPGRP1-negative or TUNEL-positive nuclei in a given anterior appendage fell within the 24 h sym CI, then that animal was considered 'sym-type' for that category (protein localization or cell-death).
cured before 12 h progressed through morphogenesis, whereas 100% of animals cured at 12 h or later underwent development (Doino et al., 1995) . Light organs cured of V. fischeri after 12 h were similar to fully symbiotic light organs with respect to nuclear loss of EsPGRP1 and entry into late-stage apoptosis. In contrast, 100% of light organs cured before 12 h were protected from cell death and 80% were protected from loss of EsPGRP1. These data implicate nuclear loss of EsPGRP1 in symbiotic light organs as a component of the developmental response to the irreversible morphogenic signal delivered by V. fischeri.
TCT induced nuclear loss of EsPGRP1 in light-organ tissues
Because TCT and LPS together irreversibly signal morphogenesis at 12 h (Koropatnick et al., 2004) , we performed experiments to determine whether TCT and LPS are sufficient to trigger EsPGRP1 loss and entry into late-stage apoptosis. We took two approaches: (i) pharmacological treatment with TCT and/or LPS (or its active component lipid A) and (ii) colonization with V. fischeri mutants defective in TCT release. While treatment with V. fischeri LPS had no effect on either the nuclear localization of EsPGRP1 or late-stage apoptosis, the presence of 10 mM TCT induced a level of nuclear loss of EsPGRP1 close to that characteristic of symbiotic tissues ( Fig. 6A and  B) . Unlike regression and haemocyte trafficking (Koropatnick et al., 2004) , EsPGRP1 loss was not increased by the addition LPS/lipid A with TCT (Fig. 6B) . Because PGN monomers were not previously reported to induce apoptosis in the squid light organ, we postulated that a small amount of LPS contaminating the filter-sterilized Instant Ocean (FSIO) could have been synergizing with the TCT to A. Representative confocal micrographs of E. scolopes epithelia. Hatchling E. scolopes were exposed to 10 ng ml -1 LPS and/or 10 mM TCT and assayed for EsPGRP1-negative and TUNEL-positive nuclei at 24 h. TCT induces EsPGRP1-negative (white arrowheads) and TUNEL-positive (yellow arrows) nuclei. EsPGRP1, green; DNA, red; TUNEL, blue. B. Direct-count estimates of EsPGRP1-negative and TUNEL-positive nuclei in TCT/LPS-treated light organs (n = 10). Symbols represent groupings that are statistically different from other groups. C. Direct-count estimates of EsPGRP1-negative and TUNEL-positive nuclei in light organs colonized by V. fischeri mutants defective in TCT secretion. Dltg represents mutant strain DMA388, which is defective for three lytic transglycosylases (DltgA, DltgD, ltgY::erm) . Complementation strains carry indicated gene on the plasmid pVSV107 (Dunn et al., 2006) . Symbols represent groupings that are statistically different from non-symbiotic light organs ( † represents an intermediate level of EsPGRP1 loss that is different from both sym and non-sym). For both (B) and (C), Statistical analysis included ANOVA with Tukey's pairwise comparisons to identify statistically significant differences between time points (group error rate P Յ 0.05). Error bars represent standard error.
induce the levels EsPGRP1 loss and TUNEL-positive nuclei observed in all TCT treatments. Alternatively, because EsPGRP1 directly interacted with PGN in vitro (Fig. 2) , it remained possible that this phenotype was distinct and dependent only on the presence of PGN fragments, such as TCT. To address this matter, we included a control using a polyclonal anti-LPS antibody to inhibit any effects from contaminating LPS as previously described (Koropatnick et al., 2004) . The anti-LPS antibody had no statistically significant effect on either nuclear loss of EsPGRP1 or the induction of TUNEL (Fig. 6B) , suggesting that all of the effects could be attributed to the activity of TCT. A mutant of V. fischeri lacking three lytictransglycosylase genes (Dltg), which is unable to release TCT in vitro (Adin et al., 2009) , did not induce full EsPGRP1 and TUNEL phenotypes by 24 h when compared with wild-type colonized hatchlings (Fig. 6C) . Some residual activity was observed in light organs colonized by the Dltg mutant, which is likely due to PGN release during normal symbiont cell turnover. Partial complementation of the triple mutant with either of two single lytic-transglycosylase genes in trans restored phenotypes comparable to wildtype colonized animals. The genetic data, coupled with pharmacological application of TCT, conclusively demonstrate that PGN monomers are necessary for both normal localization changes of EsPGRP1 and induction of latestage apoptosis in the morphogenesis programme.
The TCT-induced loss of nuclear EsPGRP1 and latestage apoptosis was limited to the light-organ epithelia. In addition to light-organ tissues, we also examined the epithelia and connective tissues of the gut, gills and epidermis. In the epithelia of these three tissues, neither TCT treatment nor symbiosis was observed to have any effect on either the nuclear localization of EsPGRP1 or the induction of apoptosis (Fig. 6A and Fig. S2 ). We observed an average of four TUNEL-positive epithelial cells per hindgut of non-symbiotic animals (n = 8). Comparable levels of TUNEL-positive epithelial nuclei were found in hindguts from TCT-treated animals (n = 7). Every TUNELpositive epithelial nucleus lacked staining for EsPGRP1, a characteristic that contrasted with nuclei from neighbouring non-apoptotic gut epithelial cells, which strongly stained for EsPGRP1. These data show that TCT is a specific morphogen of the light organ and that other tissues are insensitive to its effects. In addition, it appears that nuclear loss of EsPGRP1 is a common component of the apoptotic pathway in E. scolopes epithelial cells whether they are responding to TCT or some alternate apoptotic stimulus.
Discussion
In this study, we characterized the cellular dynamics of EsPGRP1 in symbiont-induced tissue destruction in the light organ of E. scolopes, a process in which apoptosis is a hallmark character (Fig. 1C) . We provide evidence that: (i) EsPGRP1 is a nuclear protein of the E. scolopes epithelia; (ii) in the light organ, the nuclear localization of EsPGRP1 is lost during the course of symbiont-induced morphogenesis; (iii) the alteration of EsPGRP1 localization is morphologically, temporally and spatially correlated with programmed cell death as a component of lightorgan development; and (iv) nuclear loss of EsPGRP1 and subsequent entry into late-stage apoptosis are induced by the light-organ morphogen, TCT, implicating EsPGRP1 dynamics in light-organ development.
The nuclear localization of EsPGRP1 is unprecedented and, to our knowledge, no other PGRPs have been reported to localize to the nucleus. While the EsPGRP1 protein contains no obvious nuclear localization signals, some proteins with molecular weights less than~50 kDa can passively diffuse into the nucleus (Talcott and Moore, 1999) . Passive diffusion alone would likely result in an even distribution of protein between the cytoplasm and the nucleus. However, EsPGRP1 concentrates in the nucleus relative to the cytoplasm. This uneven distribution suggests that some mechanism other than passive diffusion must also contribute to the cellular localization of EsPGRP1; for example, binding to nuclear elements may be responsible for sequestering EsPGRP1, or EsPGRP1 may specifically bind to an unknown protein with a strong nuclear localization signal resulting in nuclear import.
Multiple lines of evidence tie the nuclear localization dynamics of EsPGRP1 to the apoptotic process. EsPGRP1 was lost from nuclei with morphologies consistent with apoptosis, and these EsPGRP1-negative nuclei occurred with a frequency similar to that observed for apoptotic cells during light-organ morphogenesis (Foster et al., 1998; Koropatnick et al., 2004) . All TUNELpositive nuclei were EsPGRP1-negative and loss of nuclear EsPGRP1 occurred shortly after chromatin condensation, and prior to the re-distribution and breakdown of nucleoporins (Fig. 4) . The timing of EsPGRP1 loss from the nucleus was consistent with that reported for apoptosis in the light organ. Chromatin condensation peaks between 12 and 14 h (Foster et al., 1998) and the nuclear loss of EsPGRP1 was first observed to increase significantly in this time frame (Fig. 5) . Further, we observed the onset of nuclear loss of EsPGRP1 consistently ahead of the onset of DNA cleavage (TUNEL), suggesting that removal of EsPGRP1 is permissive to apoptotic progression (Fig. 5) . The timing of DNA cleavage observed in this study, using a fluorometric TUNEL assay, is consistent with the previously published timing of DNA cleavage and late-stage apoptosis in the light organ based on observations of cellular morphology and colorimetric TUNEL assays in histological sections (Montgomery et al., 1994; Foster et al., 1998) . Thus, the timing described here is unlikely to be due to differences in sensitivity of the TUNEL and EsPGRP1 nuclear loss assays. We conclude that nuclear loss of EsPGRP1 occurs during the apoptotic process, following chromatin condensation and preceding reorganization of the nuclear envelope and DNA cleavage.
An association between PGRPs and apoptosis has begun to gain recognition. Genetic studies of PGRPs have revealed that they can both activate and be activated by the transcription factor NF-kB, a known regulator of apoptosis (Beg and Baltimore, 1996; Michel et al., 2001; Kaneko et al., 2004; Lang et al., 2008) . Drosophila PGRP-LF mutants are developmentally defective in wing formation, including the aberrant appearance of apoptotic cells in the wing imaginal discs (Maillet et al., 2008) . The correlation of EsPGRP1 activity and apoptosis within E. scolopes epithelial cells further supports the relationship between the PGRP family of innate immunity proteins and animal development through control and/or interaction with apoptosis pathways.
In experiments with bacterial cell envelope components known to induce morphogenesis in the light organ, TCT was capable of inducing a full EsPGRP1 response with little or no contribution from lipid A or LPS. However, treatment with TCT or TCT + LPS failed to induce the full apoptotic response that is induced by V. fischeri, that is, including late-stage apoptosis as visualized by TUNEL (Fig. 6B) . Earlier studies of apoptosis induction by TCT + LPS used an early-stage cell-death indicator, chromatin condensation visualized by acridine orange staining (Koropatnick et al., 2004) . In that study, a dose-response analysis was performed to determine the concentrations of TCT + LPS that most closely mimicked the onset of cell death by the symbiont, which provided the basis for concentrations used in the present study. Thus, it is likely that the failure of the TCT + LPS to induce the full programme is not due to their concentration. However, subtle differences may exist in the way these molecules are presented by intact bacteria compared with pharmacological treatment, such that purified cell envelope constituents are fully capable of inducing early-stage, but not latestage, apoptosis. Alternatively, the symbionts may be providing a third morphogenic signal, which complements TCT + LPS under natural conditions. Candidates for additional morphogenic signals include other cell surface molecules of the symbiont, such as the flagellins and the Syp exopolysaccharide, both of which are important early in colonization (Millikan and Ruby, 2004; Yip et al., 2005) . Symbiont luminescence, another possible signal, has been shown to have specific effects on morphogenesis. Bioluminescence is induced following colonization of the deep crypts. V. fischeri luxA mutants, which fail to produce light, are attenuated in their ability to induce host haemocyte trafficking (Koropatnick et al., 2007) and cell swelling (Visick et al., 2000) , and are delayed in regression (T.A. Koropatnick and M.J. McFall-Ngai, unpubl. data) . It is intriguing to speculate that the slowed morphogenesis in animals colonized by luxA mutants could be due to a reduction in the speed of apoptosis due to the lack of symbiotic bioluminescence. Future studies will investigate whether dark mutants of V. fischeri are also deficient in their induction of the nuclear loss of EsPGRP1 and late-stage apoptosis.
Microarray studies of the onset of the symbiosis revealed that EsPGRP1 mRNA levels are increased at 18 h following inoculation in animals colonized by V. fischeri, that is, concurrent with the loss of EsPGRP1 from the nuclei of the superficial epithelial field. In addition, luxA mutants fail to induce the full increase in EsPGRP1 transcript levels characteristic of colonization with wildtype V. fischeri (Chun et al., 2008) . The findings that the luxA mutants are delayed in regression and show lower levels of EsPGRP1 mRNA suggest that these symbionttriggered increases in EsPGRP1 gene transcription are important for the induction of full morphogenesis. How this upregulation interfaces with the eventual loss of the protein from the nuclei of the cells of the superficial epithelial field remains to be determined.
It is unclear whether the activity of TCT is the result of a direct interaction with EsPGRP1 or works through an intermediary receptor/signal transduction pathway. Genetic evidence from D. melanogaster suggests that TCT can be transported across host cell membranes (Kaneko et al., 2006) , so it is conceivable that TCT could gain access to the cytoplasm and the nucleus, via passive diffusion, of light-organ epithelial cells. We attempted to determine the location of TCT in host tissue through a suite of approaches including confocal microscopy of hatchling E. scolopes treated with FITC-labelled TCT (data not shown) (Flak and Goldman, 1998) and Nano-SIMS tracing of stable isotope labelled TCT (Fig. S4 ) (Lechene et al., 2006) . To our knowledge, the localization of TCT in host cells has not been accomplished in any system. In the present study, we were unable to detect TCT associated with the host tissue. However, apoptotic cells in tissues that are unresponsive to TCT undergo nuclear loss of EsPGRP1, suggesting that this process is a component of apoptosis, independent of TCT induction. Thus, it seems unlikely that EsPGRP1 is responding directly to TCT. EsPGRP4 is an obvious candidate for a TCT-receptor because this protein is expressed in the light organ, contains a putative transmembrane domain, and topology prediction programmes suggest that the PGRP domain would be localized on the extracellular membrane surface (Goodson et al., 2005) . However, the cytoplasmic domain of this putative integral membrane protein is small, providing few clues as to possible down-stream signalling pathways that could potentially result in activation of apoptosis and morphogenesis. Recently, an intranuclear bacterial pathogen of bivalve mollusks, Candidatus Endonucleobacter bathymodioli, was characterized (Zielinski et al., 2009) , suggesting a selection pressure that could explain the nuclear localization of EsPGRP1. It is easy to envision that rapidly inducing apoptosis upon intranuclear invasion by a pathogen would limit the infectious potential of such a pathogen by inhibiting its access to the energy-rich molecules of the nucleus. In such a scenario, it would seem likely that this immune associated apoptosis was co-opted for developmental regulation during the establishment of the squid/ vibrio mutualism.
Whereas this is the first report of a nuclear PGRP associated with apoptosis, we expect that this phenomenon is not unique. An interesting avenue for further research will be the determination of the mechanistic link to apoptosis. We predict that future studies of intracellular localization of PGRPs among the marine invertebrates will reveal other nuclear members of the PGRP protein family. Further, while the study of PGRPs has primarily focused on their roles in ameliorating pathogenesis, we demonstrate a role for these proteins in mutualistic associations of animals with their bacterial partners.
Experimental procedures
General methods
Unless otherwise noted, all chemicals were purchased from Sigma-Aldrich (St. Louis, MO).
Adult E. scolopes were caught in shallow coastal waters of Oahu and maintained and bred in the lab as previously described (Montgomery and McFall-Ngai, 1993) . Juvenile squid used in experiments were collected within 10 min of hatching, washed three times in FSIO, and placed in scintillation vials containing either FSIO (non-symbiotic) or FSIO + 5 ¥ 10 3 cfu ml -1 of V. fischeri ES114 grown in LBS or SWT broth at 28°C (symbiotic). The Dltg mutant (ES114-derivative strain DMA388: DltgA, DltgD, ltgY::erm) and its derivatives were used at 2 ¥ 10 3 cfu ml -1 (Adin et al., 2009) . In these experiments, ES114 was used at identical concentrations to V. fischeri mutants. All animal experiments were carried out on a 12 h light/dark cycle and colonization by V. fischeri was monitored by following luminescence using a TD-20/20 luminometer (Turner Designs, Sunnyvale, CA) (Ruby and Asato, 1993) .
In experiments in which animals were cured of their symbionts, symbiotic juveniles were exposed to 20 mg ml -1 of chloramphenicol in FSIO beginning at 8.5 or 14 h post colonization (Doino et al., 1995) and were scored at 24 h post colonization. Nonsymbiotic juveniles exposed to chloramphenicol were also analysed as a control for any effects of the antibiotic on EsPGRP1. For experiments involving bacterial cell envelope components, juvenile E. scolopes were exposed to 10 mM TCT and/or 10 ng ml -1 of either V. fischeri LPS or lipid A in FSIO for 24 h. Cell envelope components were purified from V. fischeri as previously described (Cookson et al., 1989; Apicella et al., 1994) .
Antibody generation and western blots
Rabbit polyclonal antibodies were raised against an EsPGRP1 synthetic peptide conjugated to ovalbumin (Harlan Biosciences, Indianapolis, IN). The synthetic peptide of 13 amino acids, WSHYGLRNHNKSA, was selected from the C-terminal region of EsPGRP1 because it is predicted to be highly antigenic (Lasergene Protean, DNA Star, Madison, WI) and because it contains little similarity to the other EsPGRPs ( Fig. 2A and Fig. S1 ) or other sequences in the light-organ EST database. Upon western blot analysis to test the specificity of the antisera for the EsPGRP1 antigen, squid tissues were homogenized in 20 mM sodium phosphate pH 7.4, 100 mM sodium chloride. The aqueous soluble or cytosolic fraction was obtained as the supernatant of a centrifugation of the sample at 14 000 g for 15 min. The pellet was then washed three times with the homogenization buffer and the membranes were extracted with homogenization buffer containing 1% SDS. Protein concentrations were determined using the Bradford assay. The proteins were then separated on 12.5% SDS-PAGE gel and blotted onto a PVDF membrane (Bio-Rad, Hercules, CA). The blot was blocked overnight in 20 mM Tris, pH 7.4, 300 mM sodium chloride, 0.5% bovine serum albumin (BSA) and 1% goat serum (Jackson ImmunoResearch Laboratories, West Grove, PA). AntiEsPGRP1 antibody was diluted 1:100 in the block solution and incubated with the blot overnight at room temperature. The blot was then incubated with the secondary antibody, a goat antirabbit horseradish peroxidase-conjugate (Jackson ImmunoResearch Laboratories, West Grove, PA) at a 1:3000 dilution. Reactivity was visualized using Pierce ECL Chemiluminescent western blot kit (Pierce, Rockford, IL).
TCT degradation assays
The EsPGRP1 coding sequence was PCR amplified with a C-terminal FLAG-tag using the following DNA primers: JT73, ACAGTGGATCCATGCACCATCACCATCACCATATGCACGCG TTCGGAG; and JT74, ACTGTGCGGCCGCTTATTTATCGTCAT CGTCTTTGTAGTCACCAATAATGGCACTTT. The PCR product was subsequently cloned into the pPAC-PL plasmid using the BamHI and NotI restriction enzymes. Plasmid pJT28 was constructed by subcloning the FLAG-tagged EsPGRP1 coding sequence into the pRmHa-3 expression plasmid downstream of a Cu 2+ -inducible metallothionien promoter by EcoRI and SalI restriction of the PCR product of the following primers: JT136, TACTTGAATTCATGCACCATCACCATCACCATATGCACGCGT TCG; and JT134, ACTCTGTCGACTTATTTATCGTCATCGTCT TTGTAGTC. Drosophila S2* cells were stably transfected with pJT28 as previously described (Silverman et al., 2000) . EsPGRP1 protein was induced by addition of 500 mM CuSO4 into the media for 8-12 h. Cells were then harvested, washed with PBS and frozen at -80°C.
The Cu 2+ -induced pJT28/S2* cells were resuspended in lysis buffer (20 mM Tris, pH 7.4, protease inhibitor cocktail III and 1 mM PMSF) and incubated on ice for 10 min. Sodium chloride was then added to a final concentration of 100 mM and the insoluble material was separated by centrifugation at 20 000 g for 10 min at 4°C. The supernatant was passed over an anti-FLAG antibody affinity column three times and the column was subsequently washed with 500 column volumes of TBS (20 mM Tris, pH 7.4, 150 mM Sodium chloride). Bound proteins were eluted from the column with 100 mM FLAG-peptide. Fractions containing high levels of the EsPGRP1 protein were determined by anti-FLAG immunoblots. These fractions were combined and dialysed against storage buffer (20 mM Tris, pH 7.4, 300 mM Sodium chloride, 1 mM DTT and 50% glycerol) and stored at -20°C. Anti-FLAG immunoblots were performed as above except using 4% non-fat dry milk/TBS as the blocking solution and a 1:1000 dilution of rabbit polyclonal anti-FLAG antibodies for 1 h at room temperature.
To perform the TCT-degradation assay,~370 ng of the FLAGpurified EsPGRP1 protein fraction was diluted into 500 ml of reaction buffer (50 mM ammonium acetate, pH 7, 550 mM sodium chloride, 4 mM ZnSO4 and 1% BSA) and concentrated to 9.2 ng ml -1 on a 3-kDa-molecular-weight cut-off microcon column (Millipore, Billerica, MA). Sixty-four nanograms of the EsPGRP1 protein fraction was mixed 1:1 with 1 mM TCT. The reaction was incubated at room temperature for 1 h, diluted with 86 ml HPLCgrade water and loaded onto a Betasil C18 reverse phase column (Thermo Hypersil-Keystone, Bellefonte, PA). The TCT was mobilized using a 0-15% acetonitrile gradient and detected by absorbance at 215 nm. The crude S2* cell protein extract was generated as above, excluding the anti-FLAG affinity fractionation step. To control for S2* cell-derived amidase activity, which could be contaminating the EsPGRP1-enriched protein fraction, 24 mg of the crude S2* cell protein extract was incubated with TCT for 2 h.
Immunocytochemical detection of EsPGRP1 in E. scolopes tissues
Unless otherwise noted, all fluorophores were obtained from Molecular Probes (Invitrogen, Carlsbad, CA). To prepare juvenile squid for immunocytochemistry, they were anaesthetized in FSIO + 2% ethanol and fixed with 4% paraformaldehyde in mPBS (50 mM sodium phosphate, pH 7.4, 0.45 M sodium chloride) for 18 h at 4°C. Post-fix samples were kept at 4°C throughout the remainder of the protocol. Fixed squid were washed four times for 30 min in mPBS. The light organs were removed from each juvenile, permeabolized with 1% Triton-X-100 in mPBS (mPBST) for 2 days and then blocked overnight (mPBST, 0.5% BSA, 1% goat serum). Light organs were then exposed to the EsPGRP1 antisera diluted 1:1000 in the block solution for 7 days. Light organs were washed four times for 1 h each wash with mPBST and incubated overnight again in blocking solution. Samples were then exposed overnight to fluorescent goat antirabbit antibody conjugates (FITC or TRITC, Jackson ImmunoResearch Laboratories; AlexaFluor 633) diluted 1:25 in blocking solution overnight. To counterstain the actin cytoskeleton, light organs were incubated with 165 nM Alexa Fluor 633-phalloidin in mPBST overnight. To counterstain nuclear DNA, light organs were incubated with 100 mg ml -1 RNaseA in 2¥ SSC (30 mM sodium citrate, pH 7.2, 300 mM sodium chloride) for 30 min at 37°C and then stained with either 1.5 mM propidium iodide for 5 min or 2 mM TOTO-3 for 30 min at room temperature. Apoptotic chromosomal cleavage was detected using the DeadEnd Fluorimetric TUNEL Assay kit (Promega, Madison, WI) according to manufacturer's instructions. The nuclear pore complex was visualized by immunocytochemistry as above, except the antinucleoporin mAb 414 (Covance Research Products, Denver, PA) was co-diluted 1:1000 with the anti-EsPGRP1 Ab. Light organs were mounted in Vectashield anti-bleaching medium (Vector Laboratories, Burlingame, CA) and viewed on an LSM510 laser scanning confocal microscope (Carl Zeiss Microimaging, Thornwood, NY).
Zielinski, F.U., Pernthaler, A., Duperron, S., Raggi, L., Giere, O., Borowski, C., and Dubilier, N. (2009) Fig. S2 . Localization of EsPGRP1 in symbiotic or TCT-treated E. scolopes epithelia. Representative confocal micrographs of gill, gut and head tissues from animals colonized by V. fischeri or treated with 10 mM TCT + 10 ng ml -1 LPS. Epithelial nuclei contained EsPGRP1 (yellow arrowheads) whereas non-epithelial nuclei from the gut or head connective tissues or haemocytes in the gills did not stain for EsPGRP1 (red arrows). EsPGRP1, green; DNA, red; TUNEL, blue. Fig. S3 . Non-reactivity of pre-immune serum with E. scolopes tissues. Representative confocal micrographs of the E. scolopes light organ exposed to a 1:100 dilution of serum obtained prior to exposure to the EsPGRP1 antigen. No significant cross-reactivity was observed. Pre-immune serum, green; actin cytoskeleton, blue. . The standard terrestrial ratio of 12 C 14 N to 12 C 15 N is~270 (colour indicated by arrow on colour scale). No observed deviations from this value were statistically significant. Apparent patterns, such as that in the duct lumen, reflect increased variation due to low signal. c, cytoplasm; d, duct lumen; mv, microvilli; n, nucleus.
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